lobbying_activities: 1199739

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1199739	c7863ce6-f326-41ad-a272-893a51b513c9	Q4	THE UNITED STATES PHARMACOPEIAL CONVENTION	400358632	THE UNITED STATES PHARMACOPEIAL CONVENTION	2011	fourth_quarter	PHA	- Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients. - Implementation of the Food Safety Modernization Act. - Issues regarding creating and updating monographs. - Issues regarding FDA funding. - S 1584, "Drug Safety Accountability Act of 2011", regarding advice on drug quality. - HR 1483, "Drug Safety Enhancement Act of 2011", regarding advice on drug quality.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)		60000	0	0	2012-01-19T19:10:32.827000-05:00